APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatological Non-Steroidal Anti-Inflammatory Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Analysis and Forecast 2026-2032

29 December 2025191 pages

Choose your research edition.

Industry ResearchDermatological Non-Steroidal Anti-Inflammatory Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dermatological Non-Steroidal Anti-Inflammatory Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dermatological Non-Steroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dermatological Non-Steroidal Anti-Inflammatory Drugs include LEAD CHEMICAL, Merck KGaA, Verona Pharma, Arcutis, GlaxoSmithKline PLc, Huadong Medicine, Pfizer Inc., Roche and MSD, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dermatological Non-Steroidal Anti-Inflammatory Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dermatological Non-Steroidal Anti-Inflammatory Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Dermatological Non-Steroidal Anti-Inflammatory Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dermatological Non-Steroidal Anti-Inflammatory Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dermatological Non-Steroidal Anti-Inflammatory Drugs sales, projected growth trends, production technology, application and end-user industry.

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Company

LEAD CHEMICAL

Merck KGaA

Verona Pharma

Arcutis

GlaxoSmithKline PLc

Huadong Medicine

Pfizer Inc.

Roche

MSD

Genzyme Co.

Shapuaisi

Sato Pharmaceutical

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Type

Ketotifen

Ketoconazole

Phthalin Butan

Tacrolimus

Prednisone

Loratadine

Cyclosporine A

Others

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Application

Hospital

Clinic

Others

Dermatological Non-Steroidal Anti-Inflammatory Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatological Non-Steroidal Anti-Inflammatory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatological Non-Steroidal Anti-Inflammatory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatological Non-Steroidal Anti-Inflammatory Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dermatological Non-Steroidal Anti-Inflammatory Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dermatological Non-Steroidal Anti-Inflammatory Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dermatological Non-Steroidal Anti-Inflammatory Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Ketotifen Major Manufacturers Table 3. Ketoconazole Major Manufacturers Table 4. Phthalin Butan Major Manufacturers Table 5. Tacrolimus Major Manufacturers Table 6. Prednisone Major Manufacturers Table 7. Loratadine Major Manufacturers Table 8. Cyclosporine A Major Manufacturers Table 9. Others Major Manufacturers Table 10. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Hospital Major Manufacturers Table 12. Clinic Major Manufacturers Table 13. Others Major Manufacturers Table 14. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Trends Table 15. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Drivers Table 16. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Opportunities and Challenges Table 17. Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Restraints Table 18. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2021-2026) Table 22. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2027-2032) Table 23. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 24. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2021-2026) & (Units) Table 25. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2027-2032) & (Units) Table 26. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2021-2026) Table 27. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2027-2032) Table 28. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2021-2026) Table 32. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 33. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers, Product Type & Application Table 36. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2021-2026) Table 43. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2027-2032) Table 44. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type 2021 VS 2025 VS 2032 (Units) Table 45. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 46. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 47. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2021-2026) Table 48. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2027-2032) Table 49. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2026) & (US$/Unit) Table 50. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2027-2032) & (US$/Unit) Table 51. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2021-2026) Table 55. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2027-2032) Table 56. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application 2021 VS 2025 VS 2032 (Units) Table 57. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 58. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 59. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2021-2026) Table 60. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2027-2032) Table 61. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2026) & (US$/Unit) Table 62. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2027-2032) & (US$/Unit) Table 63. LEAD CHEMICAL Company Information Table 64. LEAD CHEMICAL Business Overview Table 65. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 67. LEAD CHEMICAL Recent Development Table 68. Merck KGaA Company Information Table 69. Merck KGaA Business Overview Table 70. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 72. Merck KGaA Recent Development Table 73. Verona Pharma Company Information Table 74. Verona Pharma Business Overview Table 75. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 77. Verona Pharma Recent Development Table 78. Arcutis Company Information Table 79. Arcutis Business Overview Table 80. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 82. Arcutis Recent Development Table 83. GlaxoSmithKline PLc Company Information Table 84. GlaxoSmithKline PLc Business Overview Table 85. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 87. GlaxoSmithKline PLc Recent Development Table 88. Huadong Medicine Company Information Table 89. Huadong Medicine Business Overview Table 90. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 92. Huadong Medicine Recent Development Table 93. Pfizer Inc. Company Information Table 94. Pfizer Inc. Business Overview Table 95. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 97. Pfizer Inc. Recent Development Table 98. Roche Company Information Table 99. Roche Business Overview Table 100. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 102. Roche Recent Development Table 103. MSD Company Information Table 104. MSD Business Overview Table 105. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 107. MSD Recent Development Table 108. Genzyme Co. Company Information Table 109. Genzyme Co. Business Overview Table 110. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 112. Genzyme Co. Recent Development Table 113. Shapuaisi Company Information Table 114. Shapuaisi Business Overview Table 115. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 117. Shapuaisi Recent Development Table 118. Sato Pharmaceutical Company Information Table 119. Sato Pharmaceutical Business Overview Table 120. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio Table 122. Sato Pharmaceutical Recent Development Table 123. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 126. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 127. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 132. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 133. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 139. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 140. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 141. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 144. Canada Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 145. Mexico Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 146. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 149. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 150. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 155. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 156. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 162. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 163. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 164. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Germany Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 167. France Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 168. U.K. Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 169. Italy Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 170. Russia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 171. Spain Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 174. Sweden Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 175. Poland Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 176. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2026) & (US$ Million) Table 177. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2027-2032) & (US$ Million) Table 178. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 179. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 180. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 181. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 182. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2026) & (US$ Million) Table 183. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2027-2032) & (US$ Million) Table 184. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 185. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 186. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 187. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 188. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 191. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 192. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 193. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 194. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 197. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 198. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 199. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 204. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 205. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 206. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 207. Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 208. Japan Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 209. South Korea Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 210. India Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 211. Australia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2026) & (Units) Table 217. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2027-2032) & (Units) Table 218. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 219. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 220. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2026) & (Units) Table 223. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2027-2032) & (Units) Table 224. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 225. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 226. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 230. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021-2026) & (Units) Table 231. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2027-2032) & (Units) Table 232. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 233. SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 234. Brazil Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 235. Argentina Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 236. Chile Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 237. Colombia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 238. Peru Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 240. Israel Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 241. UAE Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 242. Turkey Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 243. Iran Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 244. Egypt Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors List Table 248. Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Dermatological Non-Steroidal Anti-Inflammatory Drugs Image Figure 2. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Ketotifen Image Figure 5. Ketoconazole Image Figure 6. Phthalin Butan Image Figure 7. Tacrolimus Image Figure 8. Prednisone Image Figure 9. Loratadine Image Figure 10. Cyclosporine A Image Figure 11. Others Image Figure 12. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 14. Hospital Image Figure 15. Clinic Image Figure 16. Others Image Figure 17. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (2021-2032) & (US$ Million) Figure 19. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2021-2032) Figure 22. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales (2021-2032) & (Units) Figure 23. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 24. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales YoY (2021-2032) & (Units) Figure 26. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales YoY (2021-2032) & (Units) Figure 27. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales YoY (2021-2032) & (Units) Figure 28. Asia (Excluding China) Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales YoY (2021-2032) & (Units) Figure 29. South America, Middle East and Africa Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales YoY (2021-2032) & (Units) Figure 30. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2021-2032) Figure 36. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 37. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2021-2032) Figure 39. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2021-2032) Figure 42. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 43. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2021-2032) Figure 45. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Type (2021-2032) Figure 46. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Type (2021-2032) Figure 47. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Application (2021-2032) Figure 48. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Application (2021-2032) Figure 49. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Country (2021-2032) Figure 50. North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Country (2021-2032) Figure 51. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Type (2021-2032) Figure 52. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Type (2021-2032) Figure 53. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Application (2021-2032) Figure 54. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Application (2021-2032) Figure 55. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Country (2021-2032) Figure 56. Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Country (2021-2032) Figure 57. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Type (2021-2032) Figure 58. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Share by Type (2021-2032) Figure 59. China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Share by Application (2021-2032) Figure 60. China Dermat

Scope & coverage.

Types
  • Ketotifen
  • Ketoconazole
  • Phthalin Butan
  • Tacrolimus
  • Prednisone
  • Loratadine
  • Cyclosporine A
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • LEAD CHEMICAL
  • Merck KGaA
  • Verona Pharma
  • Arcutis
  • GlaxoSmithKline PLc
  • Huadong Medicine
  • Pfizer Inc.
  • Roche
  • MSD
  • Genzyme Co.
  • Shapuaisi
  • Sato Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Type
  3. 1.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Ketotifen
  5. 1.2.3 Ketoconazole
  6. 1.2.4 Phthalin Butan
  7. 1.2.5 Tacrolimus
  8. 1.2.6 Prednisone
  9. 1.2.7 Loratadine
  10. 1.2.8 Cyclosporine A
  11. 1.2.9 Others
  12. 1.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Application
  13. 1.3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Hospital
  15. 1.3.3 Clinic
  16. 1.3.4 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Dynamics
  1. 2.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Trends
  2. 2.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Drivers
  3. 2.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Opportunities and Challenges
  4. 2.4 Dermatological Non-Steroidal Anti-Inflammatory Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region
  3. 3.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region
  9. 3.4.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Manufacturers
  2. 4.1.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Manufacturers
  6. 4.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Market CR5 and HHI
  16. 4.8.2 2025 Dermatological Non-Steroidal Anti-Inflammatory Drugs Tier 1, Tier 2, and Tier 3
5 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Type
  1. 5.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type
  2. 5.1.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type
  6. 5.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type
6 Dermatological Non-Steroidal Anti-Inflammatory Drugs Market by Application
  1. 6.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application
  2. 6.1.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application
  6. 6.2.1 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application
7 Company Profiles
  1. 7.1 LEAD CHEMICAL
  2. 7.1.1 LEAD CHEMICAL Company Information
  3. 7.1.2 LEAD CHEMICAL Business Overview
  4. 7.1.3 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 LEAD CHEMICAL Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  6. 7.1.5 LEAD CHEMICAL Recent Developments
  7. 7.2 Merck KGaA
  8. 7.2.1 Merck KGaA Company Information
  9. 7.2.2 Merck KGaA Business Overview
  10. 7.2.3 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck KGaA Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  12. 7.2.5 Merck KGaA Recent Developments
  13. 7.3 Verona Pharma
  14. 7.3.1 Verona Pharma Company Information
  15. 7.3.2 Verona Pharma Business Overview
  16. 7.3.3 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Verona Pharma Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  18. 7.3.5 Verona Pharma Recent Developments
  19. 7.4 Arcutis
  20. 7.4.1 Arcutis Company Information
  21. 7.4.2 Arcutis Business Overview
  22. 7.4.3 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Arcutis Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  24. 7.4.5 Arcutis Recent Developments
  25. 7.5 GlaxoSmithKline PLc
  26. 7.5.1 GlaxoSmithKline PLc Company Information
  27. 7.5.2 GlaxoSmithKline PLc Business Overview
  28. 7.5.3 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline PLc Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  30. 7.5.5 GlaxoSmithKline PLc Recent Developments
  31. 7.6 Huadong Medicine
  32. 7.6.1 Huadong Medicine Company Information
  33. 7.6.2 Huadong Medicine Business Overview
  34. 7.6.3 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Huadong Medicine Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  36. 7.6.5 Huadong Medicine Recent Developments
  37. 7.7 Pfizer Inc.
  38. 7.7.1 Pfizer Inc. Company Information
  39. 7.7.2 Pfizer Inc. Business Overview
  40. 7.7.3 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Inc. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  42. 7.7.5 Pfizer Inc. Recent Developments
  43. 7.8 Roche
  44. 7.8.1 Roche Company Information
  45. 7.8.2 Roche Business Overview
  46. 7.8.3 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Roche Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  48. 7.8.5 Roche Recent Developments
  49. 7.9 MSD
  50. 7.9.1 MSD Company Information
  51. 7.9.2 MSD Business Overview
  52. 7.9.3 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 MSD Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  54. 7.9.5 MSD Recent Developments
  55. 7.10 Genzyme Co.
  56. 7.10.1 Genzyme Co. Company Information
  57. 7.10.2 Genzyme Co. Business Overview
  58. 7.10.3 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Genzyme Co. Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  60. 7.10.5 Genzyme Co. Recent Developments
  61. 7.11 Shapuaisi
  62. 7.11.1 Shapuaisi Company Information
  63. 7.11.2 Shapuaisi Business Overview
  64. 7.11.3 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Shapuaisi Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  66. 7.11.5 Shapuaisi Recent Developments
  67. 7.12 Sato Pharmaceutical
  68. 7.12.1 Sato Pharmaceutical Company Information
  69. 7.12.2 Sato Pharmaceutical Business Overview
  70. 7.12.3 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Sato Pharmaceutical Dermatological Non-Steroidal Anti-Inflammatory Drugs Product Portfolio
  72. 7.12.5 Sato Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
  2. 8.1.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2032)
  5. 8.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
  6. 8.2.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2032)
  9. 8.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  10. 8.3.1 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
  2. 9.1.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2032)
  5. 9.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
  6. 9.2.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2032)
  9. 9.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  10. 9.3.1 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
  2. 10.1.1 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2032)
  5. 10.2 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
  6. 10.2.1 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
  2. 11.1.1 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2032)
  5. 11.2 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
  6. 11.2.1 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2032)
  9. 11.3 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  10. 11.3.1 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Type
  2. 12.1.1 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Application
  6. 12.2.1 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Market Size by Country
  10. 12.3.1 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dermatological Non-Steroidal Anti-Inflammatory Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Value Chain Analysis
  2. 13.1.1 Dermatological Non-Steroidal Anti-Inflammatory Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dermatological Non-Steroidal Anti-Inflammatory Drugs Production Mode & Process
  6. 13.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dermatological Non-Steroidal Anti-Inflammatory Drugs Distributors
  9. 13.2.3 Dermatological Non-Steroidal Anti-Inflammatory Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst